A clinical trial described as the first of its kind found that statins can safely reduce the risk of heart attacks and strokes in healthy people over the age of 70, according to a report by The Guardian. The findings challenge long-standing uncertainty about whether older adults with no prior cardiovascular disease should be prescribed the cholesterol-lowering drugs.
Statins are among the most widely prescribed medications in the world, but their use in older healthy adults has remained a subject of debate. Concerns have centered on whether the benefits seen in younger, higher-risk populations would translate to people over 70, and whether the side effects, which can include muscle pain and increased risk of diabetes, would outweigh any gains at that age.
The trial set out to answer that question by studying healthy adults over 70 who had not previously been diagnosed with cardiovascular disease. Researchers tracked outcomes including heart attacks and strokes over the course of the study period. The results showed that statin use reduced those events and that the drugs were tolerated safely by participants in that age group.
The findings are significant because the population of adults over 70 is large and growing, and cardiovascular disease remains one of the leading causes of death and disability in that group. Current prescribing guidelines in many countries have been cautious about recommending statins for older adults who do not already have a history of heart disease or stroke.
The trial results could have implications for how doctors approach preventive cardiovascular care in older patients. Whether guidelines will be updated in response to the findings would depend on further review by medical and regulatory bodies.
